Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-30 @ 9:04 AM
Study NCT ID:
NCT04983069
Status:
UNKNOWN
Last Update Posted:
2021-11-15
First Post:
2021-07-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity
Sponsor:
University Hospital, Montpellier
Organization:
Study Overview
Official Title:
Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity
Status:
UNKNOWN
Status Verified Date:
2021-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COLONECHOGENE
Brief Summary:
Fetal colic hyper-echogenicity is a presenting symptoms for cystinuria lysinuria.
A few cases of fetuses with dibasic protein intolerance (more complex prognosis) presented with colic hyper-echogenicity antenatal.
The aim of this retrospective study is to assess the outcome of fetuses with colic hyperechogenicity in order to increase prenatal counseling
A few cases of fetuses with dibasic protein intolerance (more complex prognosis) presented with colic hyper-echogenicity antenatal.
The aim of this retrospective study is to assess the outcome of fetuses with colic hyperechogenicity in order to increase prenatal counseling
Detailed Description:
Observational multicenter retrospective study from january 2011 to january 2021.
No supplementary visit, directly related to the research, will be necessary. This study does not change the usual management of the patient.
Patients will be included after their usual medical check-up.
No supplementary visit, directly related to the research, will be necessary. This study does not change the usual management of the patient.
Patients will be included after their usual medical check-up.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: